A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
Titel:
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)
Auteur:
Pautier, P. Penel, N. Ray-Coquard, I. Italiano, A. Bompas, E. Delcambre, C. Bay, J.-O. Bertucci, F. Delaye, J. Chevreau, C. Cupissol, D. Bozec, L. Eymard, J.-C. Saada, E. Isambert, N. Guillemet, C. Rios, M. Piperno-Neumann, S. Chenuc, G. Duffaud, F.